White & Case advises Sanofi on inaugural sustainability-linked bond indexed on access to medicines
1 min read
Global law firm White & Case LLP has advised global healthcare company Sanofi on a dual-tranche bond issue that is listed on Euronext Paris and includes an inaugural sustainability-linked tranche indexed on access to medicines.
The sustainability-linked bond tranche has a nominal value of €650 million due April 2029 and bears interest at an initial 1.250% fixed annual rate. The coupon amounts are linked to Sanofi's achievement of a sustainability performance target – providing at least 1.5 million patients in 40 of the world’s poorest countries with essential medicines for the treatment of non-communicable diseases between 2022 and 2026.
The second tranche comprises €850 million fixed rate notes due April 2025 and bearing interest at an annual rate of 0.875%.
The proceeds of the bond issue will be used for general corporate purposes.
To implement its corporate strategy and issue sustainable finance instruments, Sanofi has implemented a dedicated Sustainability-Linked Bond Framework that aligns with ICMA’s Sustainability-Linked Bond Principles (2020) and has received a Second Party Opinion from ISS ESG.
The White & Case team in Paris which advised on the transaction was led by partners Olga Fedosova and Séverin Robillard and partner of counsel Cenzi Gargaro and included associate Quentin Pipieri.
For more information please speak to your local media contact.